IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Darwin Global Management, Ltd.

Q2 2025 Holdings

Filed 2025-08-14 | 5 holdings | $2.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Insmed Inc(INSM)COM PAR $.01457669307$1.9B19,344,62180.8%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$387.4M4,129,61816.3%
Cidara Therapeutics Inc(CDTX)COM NEW171757206$38.0M768,4241.6%
Merus N VCOMN5749R100$21.0M395,7380.9%
Allogene Therapeutics Inc(ALLO)COM019770106$12.4M10,479,7910.5%